Ulcerative Colitis Global Therapeutic Clinical Trials Review, H2, 2018

GlobalData
753 Pages - GLDATA66189
$2,500.00

Summary

GlobalData's clinical trial report, “Ulcerative Colitis Global Clinical Trials Review, H2, 2018" provides an overview of Ulcerative Colitis clinical trials scenario. This report provides top line data relating to the clinical trials on Ulcerative Colitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.



Companies Mentioned
Takeda Pharmaceutical Co Ltd
AbbVie Inc
Pfizer Inc
Johnson & Johnson
Shire Plc
Ferring Holding SA
Bausch Health Companies Inc
Merck & Co Inc
Astellas Pharma Inc
ICON Plc

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Ulcerative Colitis to Gastrointestinal Clinical Trials 16
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Ulcerative Colitis to Gastrointestinal Clinical Trials 21
Clinical Trials by Phase in E7 Countries 23
Clinical Trials in E7 Countries by Trial Status 24
Clinical Trials by Phase 26
In Progress Trials by Phase 27
Clinical Trials by Trial Status 28
Clinical Trials by End Point Status 30
Subjects Recruited Over a Period of Time 31
Clinical Trials by Sponsor Type 32
Prominent Sponsors 33
Top Companies Participating in Ulcerative Colitis Therapeutics Clinical Trials 35
Prominent Drugs 37
Latest Clinical Trials News on Ulcerative Colitis 38
Jul 20, 2018: Koutif Therapeutics Confirms Clinical Candidate Drug 38
Jul 19, 2018: New Phase 3 Data Show Investigational Subcutaneous Formulation of Vedolizumab Meets Primary Endpoint in Achieving Clinical Remission at Week 52 in Patients with Moderately to Severely Active Ulcerative Colitis 38
Jul 19, 2018: Abivax completes dosing in phase 2a proof-of-concept clinical trial of ABX464 in Ulcerative Colitis (ABX464-101) 39
Jul 12, 2018: Landos doses first subject cohort in Phase l trial of BT-11 for IBD 39
Clinical Trial Profile Snapshots 40
Appendix 751
Abbreviations 751
Definitions 751
Research Methodology 752
Secondary Research 752
About GlobalData 752
Contact Us 753
Source 753

List of Tables
Ulcerative Colitis Therapeutics, Global, Clinical Trials by Region, 2018* 7
Ulcerative Colitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Ulcerative Colitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Ulcerative Colitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
Ulcerative Colitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Ulcerative Colitis Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Ulcerative Colitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018* 14
Ulcerative Colitis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018* 15
Proportion of Ulcerative Colitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2018* 17
Ulcerative Colitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Ulcerative Colitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 20
Proportion of Ulcerative Colitis to Gastrointestinal Clinical Trials, E7 Countries (%), 2018* 22
Ulcerative Colitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23
Ulcerative Colitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 25
Ulcerative Colitis Therapeutics, Global, Clinical Trials by Phase, 2018* 26
Ulcerative Colitis Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 27
Ulcerative Colitis Therapeutics, Global, Clinical Trials by Trial Status, 2018* 29
Ulcerative Colitis Therapeutics Clinical Trials, Global, by End Point Status, 2018* 30
Ulcerative Colitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 31
Ulcerative Colitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 32
Ulcerative Colitis Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 34
Ulcerative Colitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 36
Ulcerative Colitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 37

List of Figures
Ulcerative Colitis Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Ulcerative Colitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Ulcerative Colitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Ulcerative Colitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
Ulcerative Colitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Ulcerative Colitis Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Ulcerative Colitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018* 14
Ulcerative Colitis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018* 15
Proportion of Ulcerative Colitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2018* 16
Ulcerative Colitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Ulcerative Colitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
Proportion of Ulcerative Colitis to Gastrointestinal Clinical Trials, E7 Countries (%), 2018* 21
Ulcerative Colitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23
Ulcerative Colitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 24
Ulcerative Colitis Therapeutics, Global, Clinical Trials by Phase (%), 2018* 26
Ulcerative Colitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 27
Ulcerative Colitis Therapeutics, Global, Clinical Trials by Trial Status, 2018* 28
Ulcerative Colitis Therapeutics Clinical Trials, Global, by End Point Status, 2018* 30
Ulcerative Colitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 31
Ulcerative Colitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 32
Ulcerative Colitis Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 33
Ulcerative Colitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 35
Ulcerative Colitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 37
GlobalData Methodology 752

$2,500.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838



Browse All Reports